ArticleMolecular therapy. Methods & clinical development2021

Testing the efficacy of a human full-length OPG-Fc analog in a severe model of cardiotoxin-induced skeletal muscle injury and repair.

Zineb Bouredji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.